Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial

BACKGROUND: The prevalence of type 2 diabetes (T2D) is increasing worldwide and creating a significant burden on health systems, highlighting the need for the development of innovative therapeutic approaches to overcome immune dysfunction, which is likely a key factor in the development of insulin r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yong, Jiang, Zhaoshun, Zhao, Tingbao, Ye, Mingliang, Hu, Chengjin, Zhou, Huimin, Yin, Zhaohui, Chen, Yana, Zhang, Ye, Wang, Shanfeng, Shen, Jie, Thaker, Hatim, Jain, Summit, Li, Yunxiang, Diao, Yalin, Chen, Yingjian, Sun, Xiaoming, Fisk, Mary Beth, Li, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716981/
https://www.ncbi.nlm.nih.gov/pubmed/23837842
http://dx.doi.org/10.1186/1741-7015-11-160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716981/
https://www.ncbi.nlm.nih.gov/pubmed/23837842
http://dx.doi.org/10.1186/1741-7015-11-160

Ejemplares similares